The FDA are being nothing else but prudent.
Have you been following the discussion? clearly not. There's no understanding of the issues in what you're saying there.
Is it prudent to condemn children to death to get data? Certain death at least 80% of the ones getting placebo will die.
Remestemcel-L reverses those figures into survival rates. Either you aren't paying attention or you're supporting your mates.
MSB to dispute FDA finding in Type A meeting, page-557
-
- There are more pages in this discussion • 461 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add MSB (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
$1.17 |
Change
-0.025(2.10%) |
Mkt cap ! $1.330B | |||
| Open | High | Low | Value | Volume |
| $1.18 | $1.22 | $1.15 | $6.344M | 5.404M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 1 | 8683 | $1.16 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $1.17 | 32999 | 1 |
View Market Depth
| Last trade - 16.10pm 15/07/2024 (20 minute delay) ? |
| MSB (ASX) Chart |